Clinical trial
Study on Safety and Clinical Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes
NCT07156773 is registered in ClinicalTrials.gov with Guangzhou Novaken Pharm Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on Safety and Clinical Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes
- Lead sponsor
- Guangzhou Novaken Pharm Co., Ltd.
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- September 3, 2025
- Completion date
- April 30, 2026
- Enrollment
- 84 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.